by James Spencer | Oct 1, 2026
On October 1st, 2026 American Antitrust Institute (AAI) honored Lowey Dannenberg, together alongside co-lead counsels, with its Outstanding Antitrust Litigation Achievement in Private Law Practice Award for our work in In re Amitiza Antitrust Litigation. In this...
by James Spencer | Jun 29, 2026
The Super Lawyers list recognizes the top 5 percent of attorneys in each state. The Rising Stars list recognizes the top 2.5 percent of attorneys in each state. Partner and COO, Gerald Lawrence, Partner, Raymond Girnys, and Of Counsel, Peter Barile, we’re...
by James Spencer | Sep 30, 2025
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. et al., No. 2:24-cv-00484 (E.D. Va.). In this case, Lowey Dannenberg represents CareFirst...
by James Spencer | Sep 22, 2025
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. Plaintiff allege that drug manufacturers Takeda and...
by James Spencer | Jul 7, 2025
Lowey Dannenberg, P.C. is pleased to welcome its newest partner, Joseph Nielsen, to the firm. Joe built a storied career in private and public roles representing victims of antitrust conspiracies in the technology and pharmaceutical industries. During his 19 years at...
